TODD CHENICEK: Open Payments
NPI 1437100724 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 26 payments from 7 companies in 2025. Trend: 2023 $1,318 · 2024 $925 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $257 |
| PFIZER INC. | 4 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Ardelyx, Inc. | 1 | $14 |
Products named: LINZESS, RINVOQ, XELJANZ, ENTYVIO, XIFAXAN, REZDIFFRA, OMVOH, CREON.
Industry payments across FL — which companies pay providers there.
